Whan In PharmLtd 미래 성장
Future 기준 확인 0/6
Whan In PharmLtd is forecast to grow earnings and revenue by 1.6% and 6.5% per annum respectively. EPS is expected to decline by 5.1% per annum. Return on equity is forecast to be 7.1% in 3 years.
주요 정보
1.6%
수익 성장률
-5.1%
EPS 성장률
| Pharmaceuticals 수익 성장 | 38.2% |
| 매출 성장률 | 6.5% |
| 향후 자기자본 수익률 | 7.1% |
| 애널리스트 커버리지 | Low |
| 마지막 업데이트 | 01 Aug 2024 |
최근 미래 성장 업데이트
Recent updates
Did Whan In Pharm Co.,Ltd. (KRX:016580) Use Debt To Deliver Its ROE Of 7.8%?
Mar 15
Here's Why I Think Whan In PharmLtd (KRX:016580) Might Deserve Your Attention Today
Feb 25Whan In Pharm Co.,Ltd.'s (KRX:016580) 1.6% Dividend Yield Looks Pretty Interesting
Feb 04
What Is The Ownership Structure Like For Whan In Pharm Co.,Ltd. (KRX:016580)?
Jan 14Why You Might Be Interested In Whan In Pharm Co.,Ltd. (KRX:016580) For Its Upcoming Dividend
Dec 24Does Whan In Pharm Co.,Ltd. (KRX:016580) Create Value For Shareholders?
Dec 11Whan In PharmLtd's (KRX:016580) Shareholders Are Down 33% On Their Shares
Nov 20수익 및 매출 성장 예측
| 날짜 | 수익 | 수익 | 잉여 현금 흐름 | 작전 현금 | 평균 애널리스트 수 |
|---|---|---|---|---|---|
| 12/31/2026 | 284,200 | 29,200 | N/A | 28,400 | 1 |
| 12/31/2025 | 266,000 | 28,000 | N/A | 26,900 | 1 |
| 12/31/2024 | 248,200 | 25,900 | N/A | 32,400 | 1 |
| 6/30/2024 | 242,456 | 29,191 | -19,428 | 22,168 | N/A |
| 3/31/2024 | 236,463 | 31,727 | -14,074 | 20,970 | N/A |
| 12/31/2023 | 230,394 | 29,774 | -8,275 | 23,197 | N/A |
| 9/30/2023 | 224,164 | 27,469 | -11,658 | 14,336 | N/A |
| 6/30/2023 | 214,684 | 25,886 | 1,729 | 24,356 | N/A |
| 3/31/2023 | 205,629 | 22,712 | 4,147 | 25,717 | N/A |
| 12/31/2022 | 198,935 | 23,921 | -17,441 | 16,851 | N/A |
| 9/30/2022 | 191,764 | 22,517 | -6,701 | 23,661 | N/A |
| 6/30/2022 | 187,376 | 23,764 | -5,201 | 22,098 | N/A |
| 3/31/2022 | 181,398 | 25,042 | 527 | 24,644 | N/A |
| 12/31/2021 | 177,776 | 26,660 | 30,556 | 35,318 | N/A |
| 9/30/2021 | 176,995 | 27,456 | 17,200 | 26,256 | N/A |
| 6/30/2021 | 175,353 | 28,898 | 16,720 | 25,706 | N/A |
| 3/31/2021 | 174,884 | 26,901 | 13,511 | 21,948 | N/A |
| 12/31/2020 | 171,705 | 23,388 | 14,531 | 22,755 | N/A |
| 9/30/2020 | 166,094 | 21,795 | 25,767 | 28,612 | N/A |
| 6/30/2020 | 163,538 | 19,548 | 27,520 | 30,277 | N/A |
| 3/31/2020 | 161,934 | 17,492 | 21,469 | 24,256 | N/A |
| 12/31/2019 | 159,177 | 18,696 | 21,716 | 24,731 | N/A |
| 9/30/2019 | 157,489 | 19,627 | 15,884 | 19,641 | N/A |
| 6/30/2019 | 156,534 | 19,971 | 12,881 | 16,638 | N/A |
| 3/31/2019 | 155,832 | 23,436 | 17,200 | 22,054 | N/A |
| 12/31/2018 | 154,664 | 21,518 | 12,863 | 17,455 | N/A |
애널리스트 미래 성장 예측
수입 대 저축률: A016580's forecast earnings growth (1.6% per year) is below the savings rate (2.6%).
수익 vs 시장: A016580's earnings (1.6% per year) are forecast to grow slower than the KR market (29.3% per year).
고성장 수익: A016580's earnings are forecast to grow, but not significantly.
수익 대 시장: A016580's revenue (6.5% per year) is forecast to grow slower than the KR market (9.9% per year).
고성장 수익: A016580's revenue (6.5% per year) is forecast to grow slower than 20% per year.
주당 순이익 성장 예측
미래 자기자본 수익률
미래 ROE: A016580's Return on Equity is forecast to be low in 3 years time (7.1%).